Outcome of prolactinoma after pregnancy and lactation: a study on 73 patients

Results of a Single-Center Observational 10-Year Survey Study on Recurrence of Hyperprolactinemia after Pregnancy and Lactation

(2012) Renata S. Auriemma et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Prolactinoma in pregnancy

(2011) Mark E. Molitch   BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM

Recurrence of hyperprolactinaemia following discontinuation of dopamine agonist therapy in patients with prolactinoma occurs commonly especially in macroprolactinoma

(2011) Thomas M. Barber et al.   CLINICAL ENDOCRINOLOGY

Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline

(2011) Shlomo Melmed et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Long term follow-up of patients with prolactinomas and outcome of dopamine agonist withdrawal: a single center experience

(2011) Panagiotis Anagnostis et al.   Pituitary

Factors determining the remission of microprolactinomas after dopamine agonist withdrawal

(2009) M. S. B. Huda et al.   CLINICAL ENDOCRINOLOGY

Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK)

(2009) Alberto Fernandez et al.   CLINICAL ENDOCRINOLOGY

Recurrence of Hyperprolactinemia after Withdrawal of Dopamine Agonists: Systematic Review and Meta-Analysis

(2009) Olaf M. Dekkers et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Prospective Study of High-Dose Cabergoline Treatment of Prolactinomas in 150 Patients

(2008) Masami Ono et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Pregnancy outcomes following cabergoline treatment: extended results from a 12-year observational study

(2007) Annamaria Colao et al.   CLINICAL ENDOCRINOLOGY